Nicholas Investment Partners, LP Lantheus Holdings, Inc. Transaction History

Nicholas Investment Partners, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	BUY	$58.87 - $83.05 $2.91 Million - $4.11 Million	49,493 New	49,493 $3.97 Million
Q3 2023 Nov 13, 2023	SELL	$60.27 - $90.75 $905,074 - $1.36 Million	-15,017 Reduced 5.57%	254,752 $17.7 Million
Q2 2023 Aug 09, 2023	SELL	$82.41 - $99.65 $8.93 Million - $10.8 Million	-108,336 Reduced 28.65%	269,769 $22.6 Million
Q1 2023 May 11, 2023	BUY	$47.76 - $82.86 $3.33 Million - $5.78 Million	69,810 Added 22.64%	378,105 $31.2 Million
Q4 2022 Feb 10, 2023	BUY	$48.76 - $77.67 $15 Million - $23.9 Million	308,295 New	308,295 $15.7 Million

542

68M

679K

423K

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $6.29B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

Get notified when there are updates to the investment portfolio of Nicholas Investment Partners, LP, based on Form 13F filings with the SEC.

Stay updated on Nicholas Investment Partners, LP with notifications on news.